Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks with little support and some other investments you should consider instead.
Evolent Health (EVH)
Forward P/E Ratio: 12.8x
Founded in 2011 to transform how healthcare is delivered to patients with complex needs, Evolent Health (NYSE:EVH) provides specialty care management services and technology solutions that help health plans and providers deliver better care for patients with complex conditions.
Why Does EVH Give Us Pause?
- Weak average lives on platform over the past two years show it’s struggled to increase its sales volumes and had to rely on price increases
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
- High net-debt-to-EBITDA ratio of 7× increases the risk of forced asset sales or dilutive financing if operational performance weakens
Evolent Health’s stock price of $4.77 implies a valuation ratio of 12.8x forward P/E. Read our free research report to see why you should think twice about including EVH in your portfolio.
Goldman Sachs (GS)
Forward P/E Ratio: 12.2x
Founded in 1869 as a small commercial paper business in New York City, Goldman Sachs (NYSE:GS) is a global financial institution that provides investment banking, securities, asset management, and consumer banking services to corporations, governments, and individuals.
Why Are We Wary of GS?
- The company has faced growth challenges as its 3.6% annual revenue increases over the last five years fell short of other financials companies
- Earnings per share lagged its peers over the last five years as they only grew by 2.6% annually
- Large asset base makes it harder to grow tangible book value per share quickly, and its annual tangible book value per share growth of 7.3% over the last five years was below our standards for the financials sector
At $886.15 per share, Goldman Sachs trades at 12.2x forward P/E. Dive into our free research report to see why there are better opportunities than GS.
Ellington Financial (EFC)
Forward P/B Ratio: 0.8x
Operating under the guidance of Ellington Management Group, a respected name in structured credit markets, Ellington Financial (NYSE:EFC) acquires and manages a diverse portfolio of mortgage-related, consumer-related, and other financial assets to generate returns for investors.
Why Do We Think EFC Will Underperform?
- Incremental sales over the last five years were less profitable as its 4.6% annual earnings per share growth lagged its revenue gains
- Tangible book value per share tumbled by 5.9% annually over the last five years, showing banking sector trends are working against it during this cycle
- Low return on equity reflects management’s struggle to allocate funds effectively
Ellington Financial is trading at $11.55 per share, or 0.8x forward P/B. Check out our free in-depth research report to learn more about why EFC doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.